Abstract
A 52-year-old man with end-stage liver disease presents with complaints of headache, tremor, ataxia, and insomnia. He reports his last alcohol consumption was 30 hours ago. He admits to a history of 15 servings of alcohol per day and a desire to abstain from alcohol. He thinks he might have had a seizure when he went without alcohol in the past. His Clinical Institute Withdrawal Assessment for Alcohol-revised (CIWA-Ar) score is 15. Is gabapentin an appropriate and adequate agent to safely take this patient through acute alcohol withdrawal syndrome (AWS) in the inpatient setting?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
